SHA:600267 Market Cap

SHA:600267 has a market cap or net worth of 12.02 billion as of March 9, 2026. Its market cap has increased by 17.10% in one year.

Market Cap

12.02B

Enterprise Value

14.15B

Revenue

9.84B

Ranking

n/a

PE Ratio

21.76

Stock Price

10.49

Market Cap Chart

Since August 15, 2006, SHA:600267's market cap has increased from 2.44B to 12.02B, an increase of 393.42%. That is a compound annual growth rate of 8.50%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	12.06B	4.85%
Dec 31, 2025	11.50B	18.59%
Dec 31, 2024	9.70B	-12.87%
Dec 29, 2023	11.13B	-13.94%
Dec 30, 2022	12.94B	-22.69%
Dec 31, 2021	16.73B	4.84%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Henan Lingrui Pharmaceutical	12.11B
Zhejiang Hisoar Pharmaceutical	11.87B
Guangdong Taienkang Pharmaceutical	12.50B
Porton Pharma Solutions	11.46B
Mayinglong Pharmaceutical Group	11.37B
Zhejiang Jingxin Pharmaceutical	12.80B
Beijing Foyou Pharma CO.,LTD	11.16B
Zhejiang CONBA Pharmaceutical	11.06B

Market Cap Rankings